OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
Yixiang Jiang, Yan Lin, Senthilkumar Krishnaswamy, et al.
Science Advances (2023) Vol. 9, Iss. 19
Open Access | Times Cited: 16

Showing 16 citing articles:

Tau-targeting therapies for Alzheimer disease: current status and future directions
Erin E. Congdon, Changyi Ji, Amber M. Tetlow, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 715-736
Closed Access | Times Cited: 113

Inhibition of tau neuronal internalization using anti-tau single domain antibodies
Clément Danis, Elian Dupré, Thomas Bouillet, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension
Jiaxin Hu, Wenchi Sha, Shuangshuang Yuan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 15023-15023
Open Access | Times Cited: 12

Single-Domain Antibody-Based Protein Degrader for Synucleinopathies
Yixiang Jiang, Yan Lin, Amber M. Tetlow, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

New prospects for 89Zr-immuno-PET in brain applications – Alpha-synucleinopathies
Thomas Wuensche, Pedro Pereira, Albert D. Windhorst, et al.
Nuclear Medicine and Biology (2024) Vol. 140-141, pp. 108969-108969
Open Access | Times Cited: 2

A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered protein
Justine Mortelecque, Orgeta Zejneli, Séverine Bégard, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 4, pp. 107163-107163
Open Access | Times Cited: 1

Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects
Sudershana Nair, Yixiang Jiang, Elizabeth Chernobelsky, et al.
Research Square (Research Square) (2024)
Open Access

Single-domain antibody-based protein degrader for synucleinopathies
Yixiang Jiang, Yan Lin, Amber M. Tetlow, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access

Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects
Sudershana Nair, Yixiang Jiang, Isabella S. Marchal, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access

单域抗体标记技术及生物医学成像应用(特邀)
周思妤 Zhou Siyu, 罗云贺 Luo Yunhe, 曾逸祺 Zeng Yiqi, et al.
Chinese Journal of Lasers (2024) Vol. 51, Iss. 15, pp. 1507102-1507102
Closed Access

Strategy of selection and optimization of single domain antibodies targeting the PHF6 linear peptide within the Tau intrinsically disordered protein
Justine Mortelecque, Orgeta Zejneli, Séverine Bégard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top